Enterprise Therapeutics stock price, funding rounds, valuation and financials

Enterprise Therapeutics has raised $59.62 m in total funding
Enterprise Therapeutics Cash, 31-Mar-2018172.6 K
Get notified regarding key financial metrics and revenue changes at Enterprise TherapeuticsLearn more
Banner background

Enterprise Therapeutics Funding

Summary Metrics

Founding Date

2014

Enterprise Therapeutics total Funding

$59.6 m

Enterprise Therapeutics latest funding size

$7.26 m

Time since last funding

2 years ago

Enterprise Therapeutics investors

Enterprise Therapeutics's latest funding round in October 2019 was reported to be $7.3 m. In total, Enterprise Therapeutics has raised $59.6 m

Enterprise Therapeutics Capital Raised

Embed Graph

Enterprise Therapeutics Balance Sheet

Annual

GBPFY, 2016FY, 2017FY, 2018

Cash

446.9k30.8k172.6k

Accounts Receivable

273.0

Current Assets

461.0k42.9k178.3k

PP&E

806.04.4k2.7k

Total Assets

461.8k47.3k181.0k

Accounts Payable

17.2k62.6k20.5k

Current Liabilities

71.5k218.6k65.4k

Total Liabilities

71.5k218.6k65.4k

Common Stock

23.024.033.0

Retained Earnings

(366.1k)(995.7k)(1.6m)

Total Equity

390.3k(171.3k)115.6k

Financial Leverage

1.2 x-0.3 x1.6 x

Enterprise Therapeutics Ratios

FY, 2016

Financial Leverage

1.2 x